Ardent Health Partners’ (NYSE:ARDT – Get Free Report) lock-up period is set to end on Tuesday, January 14th. Ardent Health Partners had issued 12,000,000 shares in its IPO on July 18th. The total size of the offering was $192,000,000 based on an initial share price of $16.00. Shares of the company owned by company insiders and major shareholders will be eligible for trade following the expiration of the lock-up period.
Wall Street Analysts Forecast Growth
ARDT has been the subject of a number of recent research reports. KeyCorp initiated coverage on shares of Ardent Health Partners in a research report on Friday, October 11th. They set an “overweight” rating and a $24.00 price objective for the company. Stephens reissued an “overweight” rating and issued a $24.00 price target on shares of Ardent Health Partners in a report on Thursday, September 19th. JPMorgan Chase & Co. restated a “neutral” rating and set a $20.00 price objective on shares of Ardent Health Partners in a research note on Tuesday, December 17th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $23.00 target price on shares of Ardent Health Partners in a research report on Thursday, November 14th. Finally, Bank of America downgraded shares of Ardent Health Partners from a “buy” rating to a “neutral” rating and reduced their price target for the company from $22.00 to $19.00 in a report on Wednesday, November 6th. Two equities research analysts have rated the stock with a hold rating, eight have issued a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, the company has an average rating of “Buy” and a consensus price target of $22.00.
Ardent Health Partners Trading Down 4.7 %
Institutional Trading of Ardent Health Partners
Hedge funds and other institutional investors have recently modified their holdings of the company. BNP Paribas Financial Markets acquired a new position in Ardent Health Partners during the third quarter worth about $42,000. Financial Management Professionals Inc. acquired a new position in shares of Ardent Health Partners in the 3rd quarter worth approximately $50,000. MetLife Investment Management LLC bought a new stake in shares of Ardent Health Partners in the 3rd quarter worth approximately $135,000. JPMorgan Chase & Co. acquired a new stake in Ardent Health Partners during the third quarter valued at approximately $154,000. Finally, Quadrature Capital Ltd bought a new stake in Ardent Health Partners during the third quarter worth approximately $229,000.
Ardent Health Partners Company Profile
Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.
Further Reading
- Five stocks we like better than Ardent Health Partners
- 3 Warren Buffett Stocks to Buy Now
- Build-Your-Bowl Battle: CAVA, Chipotle, and Sweetgreen Face Off
- Insider Trades May Not Tell You What You Think
- Insiders Are Loading Up: 3 Key Stock Picks for Investors
- How to Invest in Tech StocksĀ and Top Tech Stocks to Consider
- How Cigna Remains at the Top of the Health Insurance Food Chain
Receive News & Ratings for Ardent Health Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ardent Health Partners and related companies with MarketBeat.com's FREE daily email newsletter.